Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Facioscapulohumeral Muscular Dystrophies.

Wagner KR.

Continuum (Minneap Minn). 2019 Dec;25(6):1662-1681. doi: 10.1212/CON.0000000000000801.

PMID:
31794465
2.

Cognitive outcomes after unruptured intracranial aneurysm treatment with flow diversion.

Wagner K, Srivatsan A, Mohanty A, Srinivasan VM, Saleem Y, Cherian J, James RF, Chen S, Burkhardt JK, Johnson J, Kan P.

J Neurosurg. 2019 Nov 29:1-6. doi: 10.3171/2019.9.JNS191910. [Epub ahead of print]

PMID:
31783369
3.

Diabetes, Metformin, and Cancer Risk in Myotonic Dystrophy Type I.

Alsaggaf R, Pfeiffer RM, Wang Y, St George DMM, Zhan M, Wagner KR, Amr S, Greene MH, Gadalla SM.

Int J Cancer. 2019 Nov 20. doi: 10.1002/ijc.32801. [Epub ahead of print]

PMID:
31749144
4.

Stem cell-based therapies for Duchenne muscular dystrophy.

Sun C, Serra C, Lee G, Wagner KR.

Exp Neurol. 2020 Jan;323:113086. doi: 10.1016/j.expneurol.2019.113086. Epub 2019 Oct 19. Review.

PMID:
31639376
5.

Performing Human Skeletal Muscle Xenografts in Immunodeficient Mice.

Britson KA, Black AD, Wagner KR, Lloyd TE.

J Vis Exp. 2019 Sep 16;(151). doi: 10.3791/59966.

PMID:
31566598
6.

Mss51 deletion enhances muscle metabolism and glucose homeostasis in mice.

Rovira Gonzalez YI, Moyer AL, LeTexier NJ, Bratti AD, Feng S, Sun C, Liu T, Mula J, Jha P, Iyer SR, Lovering RM, O'Rourke B, Noh HL, Suk S, Kim JK, Essien Umanah GK, Wagner KR.

JCI Insight. 2019 Oct 17;4(20). pii: 122247. doi: 10.1172/jci.insight.122247.

7.

Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.

LoRusso S, Johnson NE, McDermott MP, Eichinger K, Butterfield RJ, Carraro E, Higgs K, Lewis L, Mul K, Sacconi S, Sansone VA, Shieh P, van Engelen B, Wagner K, Wang L, Statland JM, Tawil R; ReSolve Investigators and the FSHD CTRN18.

BMC Neurol. 2019 Sep 10;19(1):224. doi: 10.1186/s12883-019-1452-x.

8.

The NIH Toolbox for cognitive surveillance in Duchenne muscular dystrophy.

Thangarajh M, Kaat AJ, Bibat G, Mansour J, Summerton K, Gioia A, Berger C, Hardy KK, Wagner KR.

Ann Clin Transl Neurol. 2019 Sep;6(9):1696-1706. doi: 10.1002/acn3.50867. Epub 2019 Aug 31.

9.

Benign tumors in myotonic dystrophy type I target disease-related cancer sites.

Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Anderson LA, Liu Z, Koshiol J, Bauer AJ, Wagner KR, Greene MH, Amr S, Gadalla SM.

Ann Clin Transl Neurol. 2019 Aug;6(8):1510-1518. doi: 10.1002/acn3.50856. Epub 2019 Jul 26.

10.

AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult Mice.

Nance ME, Shi R, Hakim CH, Wasala NB, Yue Y, Pan X, Zhang T, Robinson CA, Duan SX, Yao G, Yang NN, Chen SJ, Wagner KR, Gersbach CA, Duan D.

Mol Ther. 2019 Sep 4;27(9):1568-1585. doi: 10.1016/j.ymthe.2019.06.012. Epub 2019 Jul 3.

PMID:
31327755
11.

Vein of Galen Malformations: The Texas Children's Hospital Experience in the Modern Endovascular Era.

Wagner KM, Ghali MGZ, Srinivasan VM, Lam S, Johnson J, Chen S, Kan P.

Oper Neurosurg (Hagerstown). 2019 Sep 1;17(3):286-292. doi: 10.1093/ons/opy369.

PMID:
31111161
12.

Long-read single-molecule maps of the functional methylome.

Sharim H, Grunwald A, Gabrieli T, Michaeli Y, Margalit S, Torchinsky D, Arielly R, Nifker G, Juhasz M, Gularek F, Almalvez M, Dufault B, Chandra SS, Liu A, Bhattacharya S, Chen YW, Vilain E, Wagner KR, Pevsner J, Reifenberger J, Lam ET, Hastie AR, Cao H, Barseghyan H, Weinhold E, Ebenstein Y.

Genome Res. 2019 Apr;29(4):646-656. doi: 10.1101/gr.240739.118. Epub 2019 Mar 7.

13.

Outcomes after coverage of lenticulostriate vessels by flow diverters: a multicenter experience.

Wagner KM, Srinivasan VM, Srivatsan A, Ghali MGZ, Thomas AJ, Enriquez-Marulanda A, Alturki AY, Ogilvy CS, Mokin M, Kuhn AL, Puri A, Grandhi R, Chen S, Johnson J, Kan P.

J Neurosurg. 2019 Jan 11:1-8. doi: 10.3171/2018.8.JNS18755. [Epub ahead of print]

PMID:
30641842
14.

Cancer Risk in Myotonic Dystrophy Type I: Evidence of a Role for Disease Severity.

Alsaggaf R, St George DMM, Zhan M, Pfeiffer RM, Wang Y, Wagner KR, Greene MH, Amr S, Gadalla SM.

JNCI Cancer Spectr. 2018 Nov;2(4):pky052. doi: 10.1093/jncics/pky052. Epub 2018 Dec 10.

15.

Outcomes and resource utilization in surgery for Chiari I malformation in a national network of children's hospitals.

LoPresti MA, Pan IW, Gadgil N, Wagner K, Lam S.

Childs Nerv Syst. 2019 Apr;35(4):657-664. doi: 10.1007/s00381-018-4012-6. Epub 2018 Dec 10.

PMID:
30536026
16.

Endoscope-assisted hemispherotomy: translation of technique from cadaveric anatomical feasibility study to clinical implementation.

Wagner K, Vaz-Guimaraes F, Camstra K, Lam S.

J Neurosurg Pediatr. 2018 Nov 2;23(2):178-186. doi: 10.3171/2018.8.PEDS18349.

PMID:
30497226
17.

Anterior Choroidal Artery Aneurysms: Influence of Regional Microsurgical Anatomy on Safety of Endovascular Treatment.

Ghali MGZ, Srinivasan VM, Wagner KM, Lam S, Johnson JN, Kan P.

J Cerebrovasc Endovasc Neurosurg. 2018 Mar;20(1):47-52. doi: 10.7461/jcen.2018.20.1.47. Epub 2018 Mar 31. Review.

18.
19.

Adipose-derived Stem/Stromal Cells on Electrospun Fibrin Microfiber Bundles Enable Moderate Muscle Reconstruction in a Volumetric Muscle Loss Model.

Gilbert-Honick J, Ginn B, Zhang Y, Salehi S, Wagner KR, Mao HQ, Grayson WL.

Cell Transplant. 2018 Oct 9:963689718805370. doi: 10.1177/0963689718805370. [Epub ahead of print]

20.

A Transition Toolkit for Duchenne Muscular Dystrophy.

Trout CJ, Case LE, Clemens PR, McArthur A, Noritz G, Ritzo M, Wagner KR, Vroom E, Kennedy A.

Pediatrics. 2018 Oct;142(Suppl 2):S110-S117. doi: 10.1542/peds.2018-0333M.

21.

Cardiac Management of the Patient With Duchenne Muscular Dystrophy.

Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK.

Pediatrics. 2018 Oct;142(Suppl 2):S72-S81. doi: 10.1542/peds.2018-0333I. Review.

22.

Neurology Care, Diagnostics, and Emerging Therapies of the Patient With Duchenne Muscular Dystrophy.

Leigh F, Ferlini A, Biggar D, Bushby K, Finkel R, Morgenroth LP, Wagner KR.

Pediatrics. 2018 Oct;142(Suppl 2):S5-S16. doi: 10.1542/peds.2018-0333C.

23.

Corrigendum to "Unplanned Intraoperative Extubations in Pediatric Neurosurgery: Analysis of Case Series to Increase Patient Safety" [World Neurosurgery 115 (2018), e1-e6].

Wagner KM, Raskin JS, Carling NP, Felberg MA, Kanjia MK, Wyatt KE, Pan IW, Luerssen TG, Lam S.

World Neurosurg. 2018 Nov;119:528. doi: 10.1016/j.wneu.2018.08.001. Epub 2018 Sep 7. No abstract available.

PMID:
30197178
24.

Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy.

Estrellas KM, Chung L, Cheu LA, Sadtler K, Majumdar S, Mula J, Wolf MT, Elisseeff JH, Wagner KR.

J Biol Chem. 2018 Oct 5;293(40):15594-15605. doi: 10.1074/jbc.RA118.004417. Epub 2018 Aug 23.

25.

Placebo-controlled Phase 2 Trial of Drisapersen for Duchenne Muscular Dystrophy.

McDonald CM, Wong B, Flanigan KM, Wilson R, de Kimpe S, Lourbakos A, Lin Z, Campion G; DEMAND V study group.

Ann Clin Transl Neurol. 2018 Jul 11;5(8):913-926. doi: 10.1002/acn3.579. eCollection 2018 Aug.

26.

Intracranial Venous Hypertension in Craniosynostosis: Mechanistic Underpinnings and Therapeutic Implications.

Ghali GZ, Zaki Ghali MG, Ghali EZ, Srinivasan VM, Wagner KM, Rothermel A, Taylor J, Johnson J, Kan P, Lam S, Britz G.

World Neurosurg. 2019 Jul;127:549-558. doi: 10.1016/j.wneu.2018.07.260. Epub 2018 Aug 6. Review.

PMID:
30092478
27.

Cognitive Sequelae of Unruptured and Ruptured Intracranial Aneurysms and their Treatment: Modalities for Neuropsychological Assessment.

Zaki Ghali MG, Srinivasan VM, Wagner K, Rao C, Chen SR, Johnson JN, Kan P.

World Neurosurg. 2018 Dec;120:537-549. doi: 10.1016/j.wneu.2018.06.178. Epub 2018 Jun 30. Review.

PMID:
29966787
28.

Engineering functional and histological regeneration of vascularized skeletal muscle.

Gilbert-Honick J, Iyer SR, Somers SM, Lovering RM, Wagner K, Mao HQ, Grayson WL.

Biomaterials. 2018 May;164:70-79. doi: 10.1016/j.biomaterials.2018.02.006. Epub 2018 Feb 20.

PMID:
29499437
29.

Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR; DMD Care Considerations Working Group.

Lancet Neurol. 2018 Mar;17(3):251-267. doi: 10.1016/S1474-4422(18)30024-3. Epub 2018 Feb 3. Review. Erratum in: Lancet Neurol. 2018 Apr 4;:.

30.

Multimodal Treatment of Intracranial Aneurysms in Children: Clinical Case Series and Review of the Literature.

Ghali MGZ, Srinivasan VM, Cherian J, Wagner KM, Chen SR, Johnson J, Lam SK, Kan P.

World Neurosurg. 2018 Mar;111:e294-e307. doi: 10.1016/j.wneu.2017.12.057. Epub 2017 Dec 18. Review.

PMID:
29269068
31.

Multivoxel proton magnetic resonance spectroscopy in facioscapulohumeral muscular dystrophy.

Leung DG, Wang X, Barker PB, Carrino JA, Wagner KR.

Muscle Nerve. 2018 Jun;57(6):958-963. doi: 10.1002/mus.26048. Epub 2018 Feb 14.

32.

Intracranial Erdheim-Chester Disease Mimicking Parafalcine Meningioma: Report of Two Cases and Review of the Literature.

Wagner KM, Mandel JJ, Goodman JC, Gopinath S, Patel AJ.

World Neurosurg. 2018 Feb;110:365-370. doi: 10.1016/j.wneu.2017.11.074. Epub 2017 Nov 28. Review.

PMID:
29191545
33.

Unplanned Intraoperative Extubations in Pediatric Neurosurgery: Analysis of Case Series to Increase Patient Safety.

Wagner KM, Raskin JS, Carling NP, Felberg MA, Kanjia MK, Pan IW, Luerssen TG, Lam S.

World Neurosurg. 2018 Jul;115:e1-e6. doi: 10.1016/j.wneu.2017.10.149. Epub 2017 Nov 3. Erratum in: World Neurosurg. 2018 Nov;119:528.

PMID:
29109066
34.

Neurosurgical management of brain metastases.

Ferguson SD, Wagner KM, Prabhu SS, McAleer MF, McCutcheon IE, Sawaya R.

Clin Exp Metastasis. 2017 Oct;34(6-7):377-389. doi: 10.1007/s10585-017-9860-z. Epub 2017 Sep 30. Review.

PMID:
28965270
35.

Surgical management of lipomyelomeningocele in children: Challenges and considerations.

Wagner KM, Raskin JS, Hansen D, Reddy GD, Jea A, Lam S.

Surg Neurol Int. 2017 Apr 26;8:63. doi: 10.4103/2152-7806.205268. eCollection 2017. Review. No abstract available.

36.

Bone health in facioscapulohumeral muscular dystrophy: A cross-sectional study.

Chagarlamudi H, Corbett A, Stoll M, Bibat G, Grosmann C, Matichak Stock C, Stinson N, Shapiro J, Wagner KR.

Muscle Nerve. 2017 Dec;56(6):1108-1113. doi: 10.1002/mus.25619. Epub 2017 Jun 5.

PMID:
28214289
37.

Left Ventricular Dysfunction and Conduction Disturbances in Patients With Myotonic Muscular Dystrophy Type I and II.

Tanawuttiwat T, Wagner KR, Tomaselli G, Nazarian S.

JAMA Cardiol. 2017 Feb 1;2(2):225-228. doi: 10.1001/jamacardio.2016.4145. No abstract available.

PMID:
27829084
38.

Validity of the 6 minute walk test in facioscapulohumeral muscular dystrophy.

Eichinger K, Heatwole C, Heininger S, Stinson N, Matichak Stock C, Grosmann C, Wagner KR, Tawil R, Statland JM; FSHD Clinical Trials Research Network.

Muscle Nerve. 2017 Mar;55(3):333-337. doi: 10.1002/mus.25251. Epub 2016 Dec 5.

39.

Morpholino-mediated Knockdown of DUX4 Toward Facioscapulohumeral Muscular Dystrophy Therapeutics.

Chen JC, King OD, Zhang Y, Clayton NP, Spencer C, Wentworth BM, Emerson CP Jr, Wagner KR.

Mol Ther. 2016 Aug;24(8):1405-11. doi: 10.1038/mt.2016.111. Epub 2016 Jun 3.

40.

Shock, but no shift: Hospitals' responses to changes in patient insurance mix.

Wagner KL.

J Health Econ. 2016 Sep;49:46-58. doi: 10.1016/j.jhealeco.2016.06.008. Epub 2016 Jun 24.

PMID:
27376908
41.

Management of Skull Base Tumor-Associated Facial Pain.

Reddy GD, Wagner K, Phan J, DeMonte F, Raza SM.

Neurosurg Clin N Am. 2016 Jul;27(3):337-44. doi: 10.1016/j.nec.2016.02.009. Review.

PMID:
27325000
42.

Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based Model.

Choi IY, Lim H, Estrellas K, Mula J, Cohen TV, Zhang Y, Donnelly CJ, Richard JP, Kim YJ, Kim H, Kazuki Y, Oshimura M, Li HL, Hotta A, Rothstein J, Maragakis N, Wagner KR, Lee G.

Cell Rep. 2016 Jun 7;15(10):2301-2312. doi: 10.1016/j.celrep.2016.05.016. Epub 2016 May 26.

43.

Clinical practice considerations in facioscapulohumeral muscular dystrophy Sydney, Australia, 21 September 2015.

Tawil R, Mah JK, Baker S, Wagner KR, Ryan MM; Sydney Workshop Participants.

Neuromuscul Disord. 2016 Jul;26(7):462-71. doi: 10.1016/j.nmd.2016.03.007. Epub 2016 Apr 25. No abstract available.

PMID:
27185458
44.

In Vivo Selection Yields AAV-B1 Capsid for Central Nervous System and Muscle Gene Therapy.

Choudhury SR, Fitzpatrick Z, Harris AF, Maitland SA, Ferreira JS, Zhang Y, Ma S, Sharma RB, Gray-Edwards HL, Johnson JA, Johnson AK, Alonso LC, Punzo C, Wagner KR, Maguire CA, Kotin RM, Martin DR, Sena-Esteves M.

Mol Ther. 2016 Aug;24(7):1247-57. doi: 10.1038/mt.2016.84. Epub 2016 Apr 27.

45.

Developing a pro-regenerative biomaterial scaffold microenvironment requires T helper 2 cells.

Sadtler K, Estrellas K, Allen BW, Wolf MT, Fan H, Tam AJ, Patel CH, Luber BS, Wang H, Wagner KR, Powell JD, Housseau F, Pardoll DM, Elisseeff JH.

Science. 2016 Apr 15;352(6283):366-70. doi: 10.1126/science.aad9272.

46.

Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.

Kornegay JN, Bogan DJ, Bogan JR, Dow JL, Wang J, Fan Z, Liu N, Warsing LC, Grange RW, Ahn M, Balog-Alvarez CJ, Cotten SW, Willis MS, Brinkmeyer-Langford C, Zhu H, Palandra J, Morris CA, Styner MA, Wagner KR.

Skelet Muscle. 2016 Apr 4;6:14. doi: 10.1186/s13395-016-0085-7. eCollection 2016.

47.

Delayed intracranial hypertension after surgery for nonsyndromic craniosynostosis.

Lam S, Wagner KM, Middlebrook E, Luerssen TG.

Surg Neurol Int. 2015 Dec 23;6:187. doi: 10.4103/2152-7806.172532. eCollection 2015. Review. No abstract available.

48.

Myositis-specific autoantibodies are specific for myositis compared to genetic muscle disease.

Mammen AL, Casciola-Rosen L, Christopher-Stine L, Lloyd TE, Wagner KR.

Neurol Neuroimmunol Neuroinflamm. 2015 Nov 19;2(6):e172. doi: 10.1212/NXI.0000000000000172. eCollection 2015 Dec.

49.

Mammalian Mss51 is a skeletal muscle-specific gene modulating cellular metabolism.

Moyer AL, Wagner KR.

J Neuromuscul Dis. 2015;2(4):371-385. Epub 2015 Sep 21.

50.

Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.

McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW; Working Group of the National Heart, Lung, and Blood Institute; Parent Project Muscular Dystrophy.

Circulation. 2015 May 5;131(18):1590-8. doi: 10.1161/CIRCULATIONAHA.114.015151. No abstract available. Erratum in: Circulation. 2015 Jun 23;131(25):e539. Groh, William J [added].

Supplemental Content

Loading ...
Support Center